KennersonLaboratory

The Northcott Neuroscience Laboratory is internationally renowned for molecular genetics of human heriditary neuropathies at the @anzacinstitute

[ern euro_nmd @euro_nmd]

➡️Next #EURONMD webinar w/ @ERN_RND & @EANeurology.

📚"Pathomechanisms of Charcot-Marie-Tooth Disease" delivered by Dr. Stefano Carlo Previtali (IRCCS Ospedale San Raffaele, Italy)

📅Oct 4th, 2023 at 16:00 CEST

ℹ️More information and registration here 👉https://t.co/ri4h9BO7KJ

[PACTALS @pactals]

#PACTALS2023 Congratulations to our oral poster winners 👏🏻👏🏻👏🏻

@BrainNerveConcord @ChineseUniversityHK @PekingUni3rdHosp

[PACTALS @pactals]

#PACTALS2023 Congratulations to our outstanding platform presenters who had the top abstracts!!!👏🏻👏🏻👏🏻

@KennersonLab
@nhokurecentre
@BrainMind_Usyd
@SeoulNatlUni

@Sicong_T @nervecentrals

[Ramesh Narayanan @RMeshNarayanan]

Job listing for neurobiologists, stem cell biologists and mouse biologists as advertised on @WhovaSupport app at the recently concluded #ANS2022. Plenty of interesting opportunities from around Oz and one from Pittsburg uni (USA). Please RT!!

[Dr Ahmad Al-Khleifat @AhmadAlKhleifat]

Impressive resources available for ID MND Initiative highlighted by @turnerMNDlab @FightMND #MND

[Lezanne @NeuralOoi]

Talk to @Dzung_doha today at poster 113 to find out more about motor neurons and astrocytes from iPSCs in ALS / MND #ANS2022

[KennersonLaboratory @KennersonLab]

Fantastic to present our results with @oxfordnanopore workshop at #ANS2022

[Ramesh Narayanan @RMeshNarayanan]

Prof. Marina Kennerson of @KennersonLab presenting recent advances on long read sequencing and genetic analysis of CMT families using @oxfordnanopore at Nanopore workshop at #ANS2022

[KennersonLaboratory @KennersonLab]

@RMeshNarayanan of @KennersonLab sharing his results for in vivo/pre-clinical models of neurodegeneration at #ANS2022

[Ramesh Narayanan @RMeshNarayanan]

@KennersonLab's recent work is out in Brain. A study by our post-doc Dr Anthony Cutrupi in collaboration with A/P Mario Saporta of @umiamimedicine
Novel gene-intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathy https://t.co/KVsBEAZEoB

[KennersonLaboratory @KennersonLab]

@RMeshNarayanan @NicholasJHunt1 Awesome!!!! Well done Nick😍

[CMT Research Foundation @CMTRF]

"Further research in repeat expansion and non-coding DNA may close the diagnostic gap in CMT" - Dr. Andrea Cortese

[CMT Research Foundation @CMTRF]

You have questions?
We have answers!

**SPOTS ARE LIMITED FOR IN-PERSON ATTENDANCE - REGISTER TODAY TO ENSURE YOUR SEAT**

Register for the 2022 Global CMT Research Convention: https://t.co/hAtA4XYRGS

#CMTRF #CMTresearch #globalCMTresearchconvention

[Ramesh Narayanan @RMeshNarayanan]

Amazing work!! More reasons to study RNA species bound and regulated by TDP-43 to understand its role in ALS and nervous system function.

[Keith N. Fargo, PhD @KeithNFargo]

When is it time for your #biotech to look at CMT as an indication? When you are looking for a rare disease with high unmet medical need, but would also benefit from a potential market of 3M ppl globally, mature natural history studies, and an existing clinical trial network.

[Gonzalo Perez Siles @gon_perez_siles]

At the @KennersonLab we have shown calpain-1 is a new gene responsible for adult onset #spinalmuscularatrophy (#SMA type 4). Our work published in #FrontiersIn Genetics expands the number of neurodegenerative diseases caused by mutations in calpain genes.
https://t.co/fklUKmwyCj

[Dr Bianca Grosz 🧬 @bianca_grosz]

Thanks to @GeneticsAus for giving me the opportunity to present my #PhD research at #GSAA21. A fantastic conference full of engaging talks and an especially unique poster session. @KennersonLab @anzacinstitute

[Keith N. Fargo, PhD @KeithNFargo]

Read about why our CEO Susan Ruediger co-founded the @CMTRF, the progress we have made in three short years, and why the future is bright for CMT treatments and cures.
https://t.co/Q7XJcxaObj

[Keith N. Fargo, PhD @KeithNFargo]

What an incredible first day of the 2021 #GlobalCMTResearchConvention. Thank you to the more than 100 participants from over 15 countries around the world who participated!
https://t.co/vNPLt2kCB9

[Julius Rönkkö @julius_ronkko]

Excellent talks from a wide variety of perspectives to tackle CMT disease. Thank you for the presenters and organizers, learned a lot! Now, last session about Clinical trial readiness! #globalcmtresearchconvention